Multicenter evaluation of the flow cytometry T-cell crossmatch - Results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists Proficiency Testing Program

被引:39
作者
Scornik, JC
Bray, RA
Pollack, MS
Cook, DJ
Marrari, M
Duquesnoy, R
Langley, JW
机构
[1] EMORY UNIV,DEPT PATHOL,ATLANTA,GA 30322
[2] BAYLOR COLL MED,HOUSTON,TX 77030
[3] METHODIST HOSP,HOUSTON,TX 77030
[4] CLEVELAND CLIN FDN,CLEVELAND,OH 44195
[5] UNIV PITTSBURGH,MED CTR,PITTSBURGH,PA 15261
[6] METHODIST MED CTR,DALLAS,TX 75203
关键词
D O I
10.1097/00007890-199705270-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The performance characteristics and interlaboratory comparisons of the T-cell flow cytometry crossmatch remain largely unknown. Methods. This study was performed using data from the ASHI-CAP proficiency testing program. Four unknown sera and two unknown cells were sent to participating laboratories twice a year for 4 years. Results. In one survey in which different crossmatch techniques were compared, flow cytometry was slightly more sensitive than the antiglobulin method and considerably more sensitive than direct cytotoxicity. However, the proportion of participants in any given survey detecting antibodies in all sera expected to be positive was 50-60% and has not changed over the years. Failure to detect antibodies correlated with low antibody concentration, diluting the unknown serum by the testing laboratory, and with the instrument used. False positive results with normal sera were infrequent. Fluorescence intensity values were not standardized and were highly variable, but when fluorescence units reported by individual laboratories were divided by their own positive-negative cutoff values, results from different centers were more comparable, In general, fluorescence-to-cutoff ratios >5 correlated with complement binding activity, whereas values <5 denoted concentrations below those required to fix complement. Conclusions. Flow cytometry, as used by most centers, is highly sensitive and allows relative antibody quantitation. Furthermore, the data define objective parameters that may help to standardize the test and improve its predictive value in clinical transplantation.
引用
收藏
页码:1440 / 1445
页数:6
相关论文
共 12 条
[1]  
BERTELI AJ, 1992, CLIN TRANSPLANT, V6, P31
[2]   No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients [J].
Christiaans, MHL ;
Overhof, R ;
tenHaaft, A ;
Nieman, F ;
vanHooff, JP ;
vandenBergLoonen, EM .
TRANSPLANTATION, 1996, 62 (09) :1341-1347
[3]  
COOK DJ, 1987, CLIN TRANSPLANT, V1, P253
[4]  
GAROVOY MR, 1983, TRANSPLANT P, V15, P1939
[5]   Evaluation of the flow cytometric crossmatch - Preliminary results of a multicenter study [J].
Harmer, AW ;
Garner, S ;
Bell, AE ;
Anyanwu, C ;
Cavanagh, G ;
Culkin, J ;
Evans, PR ;
Horsburgh, T ;
Martin, S ;
McCloskey, D ;
Reynolds, WM ;
Robson, A ;
Sutton, M ;
vanDam, MG ;
Shenton, BK .
TRANSPLANTATION, 1996, 61 (07) :1108-1111
[6]   IMPROVED GRAFT-SURVIVAL FOR FLOW-CYTOMETRY AND ANTIHUMAN GLOBULIN CROSSMATCH-NEGATIVE RETRANSPLANT RECIPIENTS [J].
KERMAN, RH ;
VANBUREN, CT ;
LEWIS, RM ;
DEVERA, V ;
BAGHDAHSARIAN, V ;
GEROLAMI, K ;
KAHAN, BD .
TRANSPLANTATION, 1990, 49 (01) :52-56
[7]   THE FLOW CYTOMETRIC CROSSMATCH AND EARLY RENAL-TRANSPLANT LOSS [J].
MAHONEY, RJ ;
AULT, KA ;
GIVEN, SR ;
ADAMS, RJ ;
BREGGIA, AC ;
PARIS, PA ;
PALOMAKI, GE ;
HITCHCOX, SA ;
WHITE, BW ;
HIMMELFARB, J ;
LEEBER, DA .
TRANSPLANTATION, 1990, 49 (03) :527-535
[8]   Identification of high- and low-risk second kidney grafts [J].
Mahoney, RJ ;
Norman, DJ ;
Colombe, BW ;
Garovoy, MR ;
Leeber, DA .
TRANSPLANTATION, 1996, 61 (09) :1349-1355
[9]  
OGURA K, 1993, TRANSPLANTATION, V56, P294
[10]  
SCORNIK JC, 1994, TRANSPLANTATION, V57, P621